Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B

Completed · Phase 3

Conditions studied: Hepatitis B, Chronic

In brief

The purpose of this study is to compare the effectiveness of entecavir plus tenofovir combination therapy with that of entecavir monotherapy. Safety will also be studied.

Key facts

Study ID
NCT00410072
Run by
Bristol-Myers Squibb
People needed
669
Starts
2007-04-01
Expected to finish
2010-10-01
Last updated by the study team
2013-03-15

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.